Karen Lewis Net Worth & Insider Trades
Karen Lewis - Chief People Officer, Apellis Pharmaceuticals, Inc
What is Karen Lewis's Net Worth?
The current estimated net worth of Apellis Pharmaceuticals, Inc's Chief People Officer, Karen Lewis, is estimated to be about $1.49M . Karen Lewis owns about 41,504 units of Apellis Pharmaceuticals, Inc common stock. In the last 2 years at Apellis Pharmaceuticals, Inc, Karen Lewis has sold an estimated value of $1.22M worth.
What is Karen Lewis's Past Insider Trading?
Karen Lewis's largest purchase order was 5,000 units , worth over $170.55K on June 2, 2023. Karen Lewis's largest sale order was 5,000 units , worth over $430K on June 2, 2023. In total, Karen Lewis has made about 12 transactions over 2 years of their time at Apellis Pharmaceuticals, Inc. Karen Lewis usually trades in January, with the busiest year in 2023.
Karen Lewis
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Karen Lewis's' Mailing Address?
- Mailing address is Apellis Pharmaceuticals, Inc. 100 5th Avenue, 3rd Floor Waltham MA 02451 MA
Apellis Pharmaceuticals, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Cedric Francois, M.D., Ph.D. | 2020 | $618,769 | $429,687 | $1,523,844 | $6,703,125 | - | $9,275,425 |
| Cedric Francois, M.D., Ph.D. | 2019 | $560,019 | $427,893 | - | $3,279,270 | - | $4,267,182 |
| Cedric Francois, M.D., Ph.D. | 2018 | $550,000 | $381,562 | - | $3,127,600 | $15,378 | $4,074,540 |
| Timothy Sullivan | 2020 | $430,269 | $244,688 | $518,129 | $2,279,063 | $13,000 | $3,485,149 |
| Timothy Sullivan | 2019 | $386,423 | $214,730 | - | $1,108,650 | $9,500 | $1,719,303 |
| Timothy Sullivan | 2018 | $380,000 | $190,000 | - | $279,250 | $10,502 | $859,752 |
| Pascal Deschatelets, Ph.D. | 2020 | $423,500 | $239,062 | $415,594 | $1,828,125 | $11,801 | $2,918,082 |
| Pascal Deschatelets, Ph.D. | 2019 | $404,077 | $252,608 | - | $1,108,650 | $55,893 | $1,821,228 |
| Pascal Deschatelets, Ph.D. | 2018 | $400,000 | $225,000 | - | $1,228,700 | $8,657 | $1,862,357 |
| Nur Nicholson | 2020 | $138,462 | $150,068 | - | $2,648,750 | $84,874 | $3,022,154 |
| Adam Townsend | 2020 | $430,038 | $217,500 | $415,594 | $1,828,125 | $9,750 | $2,901,007 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1492422/000119312521126688/d887358ddef14a.htm
What are Apellis Pharmaceuticals, Inc's Past Insider Trades?
Apellis Pharmaceuticals, Inc's most recent insider trade came on June 2, 2023 by Karen Lewis who sold 5,000 units worth $430K . In the last 6 years, insiders at Apellis Pharmaceuticals, Inc have sold an estimated value of $77.86M and bought an estimated value of $98.81M worth of shares. Insider trading is most common in February, with the busiest year in 2022. The most active traders at the company are Federico Grossi, Chief Medical Officer, Cedric Francois, Chief Executive Officer, and Alec MacHiels, Director .
Apellis Pharmaceuticals, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||